Comments
Strides Arcolab has received US-FDA approval for Vancomycin hydrochloride antibiotic capsules, used to treat bacterial infections. Shares of the company rose slightly over 6 per cent to close at Rs 631.90 following the announcement.
Vancomycin antibiotic capsules are used in the prophylaxis and treatment of infections caused by gram-positive bacteria. The drug has traditionally been reserved as a ‘last resort' remedy, used only after treatment with other antibiotics fails.
Mr Arun Kumar, Group CEO of Strides, in a statement, said: “Oral Vancomycin development is one among the many generics programmes being undertaken at the Strides group, with a special focus to develop niche and difficult to manufacture products.”
The product will be launched immediately through Alvogen, a US-based privately-owned pharmaceuticals company, on a profit share basis.
According to IMS health data, Vancomycin capsules had total US sales of $332 million for the 12 months ending February 2012, with no prior generic approvals.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.